Loberg Michael D
- SEC CIK
- 0001233414
No open-market purchases or sales filed in the past year.
Current role at each company
- IGMS IGM Biosciences, Inc.Directoras of Oct 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Loberg Michael D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2022 (view filing) | Sep 29 | 4 days | Loberg Michael DDirector | PPurchase | +5.82K | $19.62 | +$114.2K | +19.7%35.3K after | |
| Sep 29, 2022 (view filing) | Sep 27-28 | 2 days | Loberg Michael DDirector | PPurchase | +6.68K | $20.90 | +$139.6K | +29.3%29.5K after | 2 lots |
| Apr 4, 2022 (view filing) | Apr 1 | 3 days | Loberg Michael DDirector | PPurchase | +21.7K | $23.00 | +$500.0K | New position21.7K after |